Clinical Trial

Safety and Efficacy of Intravenous IDOV-Immune in Patients With Advanced Solid Tumors

Name: Safety and Efficacy of Intravenous IDOV-Immune in Patients With Advanced Solid Tumors — clinical trial record (NCT07656090)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Early Phase 1

View on ClinicalTrials.gov →

Summary

This is an open-label, dose escalation, phase I study to evaluate safety tolerability, MTD or MFD, pharmacokinetic profile, immunogenicity, and pharmacodynamic profile of IDOV-Immune in patients with advanced solid tumors.

Trial Details

NCT Number	NCT07656090
Lead Sponsor	Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions	Cancer
Enrollment	19 participants
Start Date	2025-12-18
Primary Completion	2027-10-31 (estimated)
Study Completion	2027-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-18